Potential use of angiotensin receptor blockers in skin pathologies

  • سال انتشار: 1402
  • محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 26، شماره: 7
  • کد COI اختصاصی: JR_IJBMS-26-7_002
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 214
دانلود فایل این مقاله

نویسندگان

Keshvad Hedayatyanfard

Department of Physiology, Pharmacology and Medical Physic, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

Azadeh Khalili

Department of Physiology, Pharmacology and Medical Physic, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

Hosein Karim

Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran

Soren Nooraei

Student of School of Veterinary Medicine, Faculty of Veterinary Medicine, University of Shahrekord, Shahrekord, Iran

Ehsan Khosravi

Department of Veterinary Surgery, Science and Research Branch, Islamic Azad University, Tehran, Iran

Nazgol Sadat Haddadi

Department of Dermatology, University of Massachusetts School of Medicine, Worchester, MA, USA

Ahmad Reza Dehpour

Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Gholamreza Bayat

Department of Physiology, Pharmacology and Medical Physic, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

چکیده

Renin-angiotensin system (RAS) components such as angiotensin II, angiotensin receptors (AT۱R and AT۲R), and angiotensin-converting enzyme (ACE) are expressed in different cell types of the skin. Through AT۱R, angiotensin II increases proinflammatory cytokines contributing to fibrosis, angiogenesis, proliferation, and migration of immune cells to the skin. In contrast, AT۲R suppresses the effects mentioned above. Many studies show that angiotensin receptor blockers (ARBs) and angiotensin-converting enzymes (ACEi) reduce the proinflammatory cytokines and fibrogenic factors including transforming growth factor β (TGF-β), Connective tissue growth factor (CTGF), and IL-۶. This review article provides a detailed research study on the implications of ARBs in wound healing, hypertrophic scar, and keloids. We further discuss the therapeutic potentials of ARBs in autoimmune and autoinflammatory skin diseases and cancer, given their anti-fibrotic and anti-inflammatory effects.

کلیدواژه ها

Angiotensin II, Cancer, Keloid, scar, Skin disease, Wound healing

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.